Veille Covid Long

COVID‐19 (SARS‐CoV‐2) causes multiple inflammatory complications, resulting not only in severe lung inflammation but also in harm to other organs. While current focus is on the management of acut

This cohort study describes COVID-19–related symptoms persisting 8 months after SARS-CoV-2 infection among Swedish health care workers and self-reported effects of the residual symptoms on respondents’ home, work, and social function.

Une étude menée à l’hôpital Bicêtre a évalué tous les patients ayant été hospitalisés et guéris d’une infection par SARS-CoV-2 quatre mois après leur hospitalisation. Elle met en évidence la persistance de symptôme chez un patient sur deux.

Policy Points

An estimated 700,000 people in the United States have “long COVID,” that is, symptoms of COVID‐19 persisting beyond three weeks.
COVID‐19 and its long‐term sequelae are strongl

Since May, 2020,1 increasing attention has been given to the experiences of people
with COVID-19 whose symptoms persist for 4 or more weeks. According to the Office
for National Statistics (ONS), an estimated 186 000 people (95% CI 153 000–221 000)
in private households in England currently have COVID-19 symptoms 5–12 weeks or longer
after acute infection.2 The ONS estimate that one in five people have symptoms that
persist after 5 weeks, and one in ten have symptoms for 12 weeks or longer after acute
COVID-19 infection.

Objective
Most SARS‐CoV‐2‐infected individuals never require hospitalization. However, some develop prolonged symptoms. We sought to characterize the spectrum of neurologic manifestations i